Resistance to Molecularly Targeted Therapies in Melanoma

SIMPLE SUMMARY: Metastatic melanoma has poor survival rates in comparison to other types of skin cancer. Traditional therapies are not very effective in treating advanced melanoma. For this reason, several molecular targeted therapies such as tyrosine kinase inhibitors are currently being used to tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Meet, Eckburg, Adam, Gantiwala, Shahina, Hart, Zachary, Dein, Joshua, Lam, Katie, Puri, Neelu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961479/
https://www.ncbi.nlm.nih.gov/pubmed/33807778
http://dx.doi.org/10.3390/cancers13051115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961479/
https://www.ncbi.nlm.nih.gov/pubmed/33807778
http://dx.doi.org/10.3390/cancers13051115

Ejemplares similares